Abiopharma

New Form 6-K - IM Cannabis Corp. Filed: 2025-10-23 AccNo: 0001178913-25-003552 Size: 25 KB

Exagen Announces Acceptance of Six Abstracts at 2025 American College of Rheumatology Convergence

(90% Positive) MAIA Biotechnology, Inc. (MAIA) Provides Update on ateganosine for Berlin

IM Cannabis Signs Non-Binding Term Sheet to Acquire 60% Stake in Innovative Quantum Computing Bio Data Company for Up to $54 Million

New Form 424B3 - AlphaTON Capital Corp Filed: 2025-10-23 AccNo: 0001171843-25-006622 Size: 108 KB

Solana Company (NASDAQ: HSDT) Strengthens Treasury Strategy with Helius, Anchorage Digital and Twinstake Staking Services

Nuwellis, Inc. To Report Third Quarter 2025 Financial Results on November 12, 2025

LivaNova to Present at Wolfe Research Healthcare Conference in November

New Form 6-K - AlphaTON Capital Corp Filed: 2025-10-23 AccNo: 0001171843-25-006621 Size: 99 KB

GT Biopharma Provides Enrollment Update on GTB-3650 Phase 1 Trial in Patients with Relapsed or Refractory (r/r) CD33 Expressing Hematologic Malignancies

SciSparc Notification (SPRC)

Oramed Releases Letter to Shareholders, Highlighting Developments in its Oral Insulin Program, Significant Investment Appreciation, and Upcoming Growth Initiatives

SciSparc Targets Quantum-Powered 3D Protein Modeling Technology to Revolutionize AI Drug Discovery

Entera Bio Presents Positive New Clinical Data from EB613 Phase 2 Trial Demonstrating Significant Bone Density Improvements in Early Postmenopausal Women

(70% Positive) Biofrontera Inc. (BFRI) Announces Business Combination